Exact Mass: 390.0998
Exact Mass Matches: 390.0998
Found 122 metabolites which its exact mass value is equals to given mass value 390.0998
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Dopaxanthin
Dopaxanthin is produce from the reaction between dopaxanthin quinone and water, with oxygen as the byproduct. The reaction is catalyzed by the tyrosinase precursor enzyme. Dopaxanthin can also be produced by the reaction between portulacaxanthin II, L-ascorbate, and O2, with L-dehydro-ascorbate and H2O as byproducts. The reaction is also catalyzed by the tyrosinase precursor enzyme. Dopaxanthin is produce from the reaction between dopaxanthin quinone and water, with oxygen as the byproduct. The reaction is catalyzed by the tyrosinase precursor enzyme.
5,7-Dihydroxy-2-(4-hydroxy-3-methoxy-phenyl)-3,6,8-trimethoxy-chromen-4-one
Clitoriacetal
5,3,4-Trihydroxy-3,6,7,8-tetramethoxyflavone
5,7,4-Trihydroxy-3,6,8,3-tetramethoxyflavone
3,5,4-Trihydroxy-6,7,8,3-tetramethoxyflavone
5,7,5-Trihydroxy-3,6,2,4-tetramethoxyflavone
3,5,8-Trihydroxy-6,7,3,4-tetramethoxyflavone
7-(4-Hydroxybenzoyl)-5-(hydroxymethyl)-4,5-dihydrospiro[benzofuran-2(3H),2(3H)-furan]-3,4,4,6-tetraol
Mangiferin; 1,3,6,7-Tetrahydroxy-2-beta(?)-glucosyl-xanthon
Squamatic acid
5-Hydroxy-3-methoxy-6-acetoxy-4-methyl-2.2-oxy-dibenzoesaeure-1-methylester|6-Acetoxy-5-hydroxy-3-methoxy-4-methyl-2,2-oxy-di-benzoesaeure-1-methylester|6-acetoxy-5-hydroxy-3-methoxy-4-methyl-2,2-oxy-di-benzoic acid-1-methyl ester|6-(4-Hydroxy-6-methoxy-2-methoxycarbonyl-phenoxy)-2-acetoxy-4-methyl-benzoesaeure|Asterric acid-monoacetat
2,3,6,7-Tetra-Me ether-2,3,4,5,6,6,7-Heptahydroxyflavone|2,3,6,7-tetramethoxy-4,5,6-trihydroxyflavone|4,5,6-trihydroxy-2,3,6,7-tetramethoxyflavone|6,7,2,3-tetramethoxy-5,4,6-trihydroxyflavone|NAS-3
5,7-dihydroxy-2-(3-hydroxy-4,5-dimethoxyphenyl)-3,6-dimethoxy-4H-chromen-4-one
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, carboxymethyl methyl est
triethoxy-[3-(1,1,1,2,3,3,3-heptafluoropropan-2-yloxy)propyl]silane
LY2886721
(2E)-1-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-2-buten-1-one
(3E)-1-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-3-buten-1-one
2-(3,4-Dichlorophenyl)-1-(2-(pyrrolidin-1-ylmethyl)piperidin-1-yl)ethanone hydrochloride
N-[4-chloro-5-[(4-chlorophenyl)methyl]-6-methylpyrrolo[3,2-d]pyrimidin-2-yl]-2,2-dimethylpropanamide
3-[[[(1-Oxo-2,2-diphenylethyl)amino]-sulfanylidenemethyl]amino]benzoic acid
N-[[(4-oxo-1-phenyl-5-pyrazolo[3,4-d]pyrimidinyl)amino]-sulfanylidenemethyl]benzamide
ethyl 2-anilino-5-(1H-indol-3-ylmethylene)-4-oxo-4,5-dihydro-3-thiophenecarboxylate
4-(4-Methoxyphenoxy)-2-(4-methylphenyl)-5-thiophen-2-yl-3-pyridazinone
1-[(1S,2aS,8bS)-4-(4-fluorophenyl)sulfonyl-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]ethanone
1-[(1R,2aS,8bS)-4-(4-fluorophenyl)sulfonyl-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]ethanone
1-[(1R,2aR,8bR)-4-(4-fluorophenyl)sulfonyl-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]ethanone
1-[(1S,2aR,8bR)-4-(4-fluorophenyl)sulfonyl-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]ethanone
6-[3-[(1E)-buta-1,3-dienyl]-1-oxoisochromen-5-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
[2-Hydroxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropyl] propanoate
5,7-Dihydroxy-2-(4-hydroxy-3-methoxy-phenyl)-3,6,8-trimethoxy-chromen-4-one
BRL 52537 (hydrochloride)
BRL 52537 hydrochloride is a highly selective κ-Opioid receptor (KOR) agonist with Kis of 0.24 nM and 1560 nM for κ and μ subtypes, respectively. BRL 52537 hydrochloride decreases ischemia-evoked NO production as a potential mechanism of neuroprotection. BRL 52537 hydrochloride attenuates early stroke damage[1].